First Time Loading...

ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 0.168 USD 0.18% Market Closed
Updated: May 13, 2024

ReShape Lifesciences Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ReShape Lifesciences Inc
Interest Income Expense Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
ReShape Lifesciences Inc
NASDAQ:RSLS
Interest Income Expense
$3.9m
CAGR 3-Years
408%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Interest Income Expense
-$384m
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
-16%
Boston Scientific Corp
NYSE:BSX
Interest Income Expense
-$554m
CAGR 3-Years
N/A
CAGR 5-Years
-51%
CAGR 10-Years
-6%
Stryker Corp
NYSE:SYK
Interest Income Expense
$97m
CAGR 3-Years
7%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Interest Income Expense
-$296m
CAGR 3-Years
16%
CAGR 5-Years
16%
CAGR 10-Years
-13%
Intuitive Surgical Inc
NASDAQ:ISRG
Interest Income Expense
$227m
CAGR 3-Years
11%
CAGR 5-Years
19%
CAGR 10-Years
29%

See Also

What is ReShape Lifesciences Inc's Interest Income Expense?
Interest Income Expense
3.9m USD

Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Interest Income Expense amounts to 3.9m USD.

What is ReShape Lifesciences Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
408%

The average annual Interest Income Expense growth rates for ReShape Lifesciences Inc have been 408% over the past three years .